Wells Fargo & Company SOLENO THERAPEUTICS INC Transaction History

Wells Fargo & Company

  • $468 Billion
  • Q2 2025
Number of Shares
21,160
Previous 12,473 69.65%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
BUY
N/A
8,687 Added 69.65%
21,160 $0
Q1 2025

May 13, 2025
SELL
N/A
-74 Reduced 0.59%
12,473 $0
Q4 2024

Feb 12, 2025
BUY
N/A
3,610 Added 40.39%
12,547 $0
Q3 2024

Nov 13, 2024
BUY
N/A
1,291 Added 16.88%
8,937 $0
Q2 2024

Aug 13, 2024
BUY
N/A
7,082 Added 1255.67%
7,646 $0
Q1 2024

May 10, 2024
BUY
N/A
449 Added 390.43%
564 $0
Q4 2023

Feb 09, 2024
BUY
N/A
82 Added 248.48%
115 $0
Q3 2023

Nov 13, 2023
SELL
N/A
-7 Reduced 17.5%
33 $0
Q2 2023

Aug 15, 2023
BUY
N/A
2 Added 5.26%
40 $0
Q4 2022

Feb 13, 2023
BUY
N/A
1 Added 2.7%
38 $0
Q3 2022

Nov 14, 2022
BUY
N/A
37 New
37 $0
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email